[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

about

Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis.

P2860

Q45300992-3622FCCB-2DD3-41BA-96EC-1CE3454D6EEA

P2860

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

Item

http://www.wikidata.org/entity/Q44032471

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@en

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@nl

type

Item

label

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@en

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@nl

prefLabel

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@en

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@nl

P1476

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

@en

P2093

Holger Neye

http://www.w3.org/2001/XMLSchema#string

P2860

Über Biguanide, II.: Die blutzucker-senkende Wirkung der Biguanide

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

Effects of metformin on glucose and glucagon regulated gluconeogenesis in cultured normal and diabetic hepatocytes.

The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

P304

264-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1615-1003(200205)31:3<264::AID-PAUZ264>3.0.CO;2-D

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12071123

http://www.w3.org/2001/XMLSchema#string

P921

metformin

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

about

P2860

P2860

[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921